Burney CO Pfizer Inc Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Pfizer Inc stock. As of the latest transaction made, Burney CO holds 39,619 shares of PFE stock, worth $1.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

39,619

Previous 44,822 11.61%

Holding current value

$1.05 Million

Previous $1.25 Million 8.61%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$27.7 - $31.39 $144,123 - $163,322	-5,203 Reduced 11.61%	39,619 $1.15 Million
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $147,594 - $172,952	-5,843 Reduced 11.53%	44,822 $1.25 Million
Q1 2024 May 22, 2024	SELL	$25.89 - $29.73 $117,980 - $135,479	-4,557 Reduced 8.25%	50,665 $1.41 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $367,440 - $477,264	-14,062 Reduced 20.3%	55,222 $1.59 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $58,275 - $68,118	1,816 Added 2.69%	69,284 $2.3 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $248,722 - $287,765	-6,886 Reduced 9.26%	67,468 $2.47 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $3.3 Million - $4.29 Million	-83,673 Reduced 52.95%	74,354 $3.03 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $701,650 - $915,927	-16,806 Reduced 9.61%	158,027 $8.1 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $1,619 - $1,976	37 Added 0.02%	174,833 $7.65 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $75,983 - $90,092	-1,633 Reduced 0.93%	174,796 $9.17 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $154,269 - $191,158	-3,372 Reduced 1.88%	176,429 $9.13 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $26,362 - $39,077	638 Added 0.36%	179,801 $10.6 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $166,851 - $214,335	-4,251 Reduced 2.32%	179,163 $7.71 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $50,058 - $56,707	-1,394 Reduced 0.75%	183,414 $7.18 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $69,491 - $78,372	2,075 Added 1.14%	184,808 $6.7 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $630,842 - $802,170	-18,848 Reduced 9.35%	182,733 $6.73 Million
Q3 2020 Dec 14, 2020	BUY	$31.75 - $37.25 $81,153 - $95,211	2,556 Added 1.28%	201,581 $7.4 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $142,557 - $172,943	4,733 Added 2.44%	199,025 $6.51 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $173,208 - $247,476	-6,408 Reduced 3.19%	194,292 $6.34 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $100,702 - $114,284	3,059 Added 1.55%	200,700 $7.86 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $112,025 - $145,264	-3,448 Reduced 1.71%	197,641 $7.1 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $260,893 - $292,923	7,055 Added 3.64%	201,089 $8.71 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $962,625 - $1.06 Million	25,670 Added 15.25%	194,034 $8.24 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $298,719 - $340,572	7,765 Added 4.84%	168,364 $7.35 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $294,684 - $357,433	-8,549 Reduced 5.05%	160,599 $7.08 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $660,490 - $704,149	20,027 Added 13.43%	169,148 $6.14 Million
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $59,224 - $68,709	1,856 Added 1.26%	149,121 $5.29 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $616,141 - $653,747	18,525 Added 14.39%	147,265 $5.33 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $210,118 - $231,468	-6,778 Reduced 5.0%	128,740 $4.58 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $4.2 Million - $4.63 Million	135,518	135,518 $4.56 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account